A Vision for Global Leadership – Paolo Marcucci

Kedrion President and CEO Paolo Marcucci discusses Kedrion’s goal to strengthen its role as strategic partner of national health systems.

The Human and Economic Value of Healthcare Innovation

In this issue, we explore novel technologies shaping the future of the healthcare landscape.

Crohn’s Disease: A Physician’s Perspective

David T. Rubin MD, assistant professor of medicine at the University of Chicago Pritzker School of Medicine, is a leading authority on Crohn’s disease and ulcerative colitis.

The Road to Remission

Tom Robinson refused to passively accept his diagnosis of debilitating Crohn’s disease and instead embarked on a journey that not only restored his health but launched a new career.

HIV: A Patient’s Perspective

Results from a routine physical permanently altered the course of Jacques Whitfield’s life by revealing he was HIV positive. But for this patient-turned-advocate, promoting prevention has become his life’s passion.

Immunization: An Era of Innovation

As we celebrate our third year in publication, we begin by exploring innovations in vaccine research and technology.

Leading the Way in Vaccine Innovation: Brent MacGregor

Brent MacGregor, president of Novartis Vaccines, U.S., plans to build upon the current Novartis Vaccines culture, which he says promotes an entrepreneurial spirit coupled with an element of risk-taking that he thrives on.

HIV: A Physician’s Perspective

Improved medications and lowered mortality rates have tasked providers with helping patients not only adhere to treatment plans, but also navigate the emotional and social implications of living long term with HIV.

Meeting the Needs of Patients Globally: Gregory Rich

With a global presence in more than90 countries, Grifols had long established itself as a standard-bearer within the plasma therapies industry.

Danger Ahead: The Growing Safety Challenges

With the number of counterfeit drug investigations having grown almost tenfold in the last five years, the number of prescription drug shortages nearly tripling from 2005 to 2010, and with recent indications that this threat is increasing rather than diminishing, keeping patients safe has never been more challenging.